JANE STREET GROUP, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$4,644,000
-41.0%
30,716
-43.1%
0.00%
-33.3%
Q2 2022$7,867,000
-63.9%
53,994
-70.6%
0.00%
-57.1%
Q1 2022$21,809,000
+59.0%
183,940
+84.8%
0.01%
+40.0%
Q4 2021$13,717,000
-39.3%
99,537
-38.8%
0.01%
-28.6%
Q3 2021$22,598,000
+109.2%
162,678
+46.2%
0.01%
+75.0%
Q2 2021$10,802,000
+553.9%
111,260
+360.6%
0.00%
Q1 2021$1,652,000
-87.6%
24,155
-84.4%
0.00%
-100.0%
Q4 2020$13,278,000
+462.9%
154,911
+327.1%
0.01%
+600.0%
Q3 2020$2,359,000
-77.5%
36,272
-74.7%
0.00%
-87.5%
Q2 2020$10,475,000
+198.5%
143,280
+39.0%
0.01%
+166.7%
Q1 2020$3,509,000
+155.0%
103,109
+308.0%
0.00%
+50.0%
Q4 2019$1,376,000
-24.9%
25,272
-42.5%
0.00%
-33.3%
Q3 2019$1,833,000
+85.2%
43,934
+94.4%
0.00%
+50.0%
Q2 2019$990,000
+85.7%
22,604
+59.3%
0.00%
+100.0%
Q3 2018$533,000
-20.1%
14,189
-16.0%
0.00%
-50.0%
Q2 2018$667,000
+107.1%
16,884
+34.9%
0.00%
+100.0%
Q1 2018$322,00012,5190.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 896,844$123,594,00067.92%
RP Management, LLC 1,111,111$153,122,00064.09%
ORACLE INVESTMENT MANAGEMENT INC 2,075,402$286,011,00040.64%
ARS Investment Partners, LLC 463,392$63,860,0005.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 300,373$41,394,0004.76%
SILVERARC CAPITAL MANAGEMENT, LLC 80,348$11,073,0004.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,900$19,282,0004.30%
Avidity Partners Management LP 1,140,000$157,103,0003.33%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$27,562,0003.17%
Eventide Asset Management 1,635,000$225,319,0002.88%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders